A study of the relationship between pharmacologic preconditioning and adenosine triphosphate-sensitive potassium (KATP) channels on cultured cardiomyocytes using the microelectrode array

Journal of Cardiovascular Pharmacology

Volumn 56, Issue 1, 2010, Pages 60-68

  Law, Jessica Ka Yan ^a   Yeung, Chi Kong ^b   Yiu, Ka Lap ^b   Rudd, John Anthony ^b   Ingebrandt, Sven ^c   Chan, Mansun ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c UNIVERSITY OF APPLIED SCIENCES KAISERSLAUTERN   (Germany)

Author keywords

ischemia; KATP channels; microelectrode array; pharmacologic preconditioning; potassium channel openers; rat cardiomyocytes

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CONNEXIN 43; DIAZOXIDE; PINACIDIL; MITOCHONDRIAL K(ATP) CHANNEL; POTASSIUM CHANNEL; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; EMBRYO; HEART BEAT; HEART MUSCLE CELL; ISCHEMIA; ISCHEMIC PRECONDITIONING; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEART INFARCTION PREVENTION; METABOLISM; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CONNEXIN 43; DIAZOXIDE; ELECTROPHYSIOLOGY; GENE EXPRESSION REGULATION; ISCHEMIC PRECONDITIONING, MYOCARDIAL; KATP CHANNELS; MICROELECTRODES; MYOCYTES, CARDIAC; PINACIDIL; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

EID: 77955228561     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181e0bab6     Document Type: Article

References (41)

1. Zaugg M, Schaub MC. Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning. J Muscle Res Cell Motil. 2003;24:219-249.
2. Przyklenk K, Simkhovich BZ, Bauer B, et al. Cellular mechanisms of infarct size reduction with ischemic preconditioning. Role of calcium? Ann N Y Acad Sci. 1999;874:192-210.
3. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74:1124-1136.
4. Pagliaro P, Gattullo D, Rastaldo R, et al. Ischemic preconditioning: from the first to the second window of protection. Life Sci. 2001;69:1-15.
5. Jenkins DP, Pugsley WB, Alkhulaifi AM, et al. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart. 1997;77:314-318.
6. Mikhail P, Verma S, Fedak PW, et al. Does ischemic preconditioning afford clinically relevant cardioprotection? Am J Cardiovasc Drugs. 2003;3:1-11.
7. Cohen MV, Downey JM. Adenosine: trigger and mediator of cardioprotection. Basic Res Cardiol. 2008;103:203-215.
8. Gross G. Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol. 2003;35:709-718.
9. Akula A, Veeravalli KK, Potharaju S, et al. Studies on the signal cascade mechanism mediating the cardioprotective actions of bradykinin. Pharmazie. 2002;57:332-336.
10. Zaugg M, Lucchinetti E, Uecker M, et al. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth. 2003;91:551-565.
11. Fryer RM, Auchampach JA, Gross GJ. Therapeutic receptor targets of ischemic preconditioning. Cardiovasc Res. 2002;55:520-525.
12. Das M, Das D. Molecular mechanism of preconditioning. IUBMB Life. 2008;60:199-203.
13. Tamargo J, Caballero R, Gomez R, et al. Pharmacology of cardiac potassium channels. Cardiovasc Res. 2004;62:9-33.
14. Wang Y, Haider H, Ahmad N, et al. Mechanisms by which K(ATP) channel openers produce acute and delayed cardioprotection. Vascul Pharmacol. 2005;42:253-264.
15. Gross GJ, Fryer RM. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res. 1999;84:973-979.
16. Jongsma HJ,Wilders R. Gap junctions in cardiovascular disease. Circ Res. 2000;86:1193-1197.
17. Hesketh GG, Van Eyk JE, Tomaselli GF. Mechanisms of gap junction traffic in health and disease. J Cardiovasc Pharmacol. August 20, 2009. [Epub ahead of print].
18. Desplantez T, Dupont E, Severs NJ, et al. Gap junction channels and cardiac impulse propagation. J Membr Biol. 2007;218:13-28.
19. Zeevi-Levin N, Barac YD, Reisner Y, et al. Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res. 2005;66:64-73.
20. Reisner Y, Meiry G, Zeevi-Levin N, et al. Impulse conduction and gap junctional remodelling by endothelin-1 in cultured neonatal rat ventricular myocytes. J Cell Mol Med. 2009;13:562-573.
21. van Rijen HV, de Bakker JM, van Veen TA. Hypoxia, electrical uncoupling, and conduction slowing: role of conduction reserve. Cardiovasc Res. 2005;66:9-11.
22. Armstrong SC, Liu GS, Downey JM, et al. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil. J Mol Cell Cardiol. 1995;27:1765-1774.
23. Yeung CK, Sommerhage F, Wrobel G, et al. Drug profiling using planar microelectrode arrays. Anal Bioanal Chem. 2007;387:2673-2680.
24. Tanno M, Miura T, Tsuchida A, et al. Contribution of both the sarcolemmal K(ATP) and mitochondrial K(ATP) channels to infarct size limitation by K(ATP) channel openers: differences from preconditioning in the role of sarcolemmal K(ATP) channels. Naunyn Schmiedebergs Arch Pharmacol. 2001;364:226-232.
25. Ghosh S, Standen NB, Galinanes M. Evidence for mitochondrial K ATP channels as effectors of human myocardial preconditioning. Cardiovasc Res. 2000;45:934-940.
26. Hu H, Sato T, Seharaseyon J, et al. Pharmacological and histochemical distinctions between molecularly defined sarcolemmal KATP channels and native cardiac mitochondrial KATP channels. Mol Pharmacol. 1999; 55:1000-1005.
27. Diaz RJ, Wilson GJ. Studying ischemic preconditioning in isolated cardiomyocyte models. Cardiovasc Res. 2006;70:286-296.
28. Saltman AE, Krukenkamp IB, Gaudette GR, et al. Pharmacological preconditioning with the adenosine triphosphate-sensitive potassium channel opener pinacidil. Ann Thorac Surg. 2000;70:595-601.
29. Di Lisa F, Canton M, Menabo R, et al. Mitochondria and cardioprotection. Heart Fail Rev. 2007;12:249-260.
30. Sedmera D, Kucera P, Raddatz E. Developmental changes in cardiac recovery from anoxia-reoxygenation. Am J Physiol Regul Integr Comp Physiol. 2002;283:R379-R388.
31. Yeung CK, Sommerhage F, Wrobel G, et al. To establish a pharmacological experimental platform for the study of cardiac hypoxia using the microelectrode array. J Pharmacol Toxicol Methods. 2009;59:146-152.
32. Simon F, Varela D, Riveros A, et al. Non-selective cation channels and oxidative stress-induced cell swelling. Biol Res. 2002;35:215-222.
33. Shaw RM, Rudy Y. Electrophysiologic effects of acute myocardial ischemia: a theoretical study of altered cell excitability and action potential duration. Cardiovasc Res. 1997;35:256-272.
34. Garcia-Dorado D, Ruiz-Meana M, Padilla F, et al. Gap junction-mediated intercellular communication in ischemic preconditioning. Cardiovasc Res. 2002;55:456-465.
35. Kleber AG. Resting membrane potential, extracellular potassium activity, and intracellular sodium activity during acute global ischemia in isolated perfused guinea pig hearts. Circ Res. 1983;52:442-450.
36. Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev. 2004;84:431-488.
37. Allen DG, Orchard CH. Myocardial contractile function during ischemia and hypoxia. Circ Res. 1987;60:153-168.
38. Halbach M, Egert U, Hescheler J, et al. Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures. Cell Physiol Biochem. 2003;13:271-284.
39. Kicinska A, Szewczyk A. Protective effects of the potassium channel opener-diazoxide against injury in neonatal rat ventricular myocytes. Gen Physiol Biophys. 2003;22:383-395.
40. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res. 2004;94:7-16.
41. Heinzel FR, Luo Y, Li X, et al. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res. 2005;97:583-586.